Clinical Trial Update: A Study of Atengenal and Astugenal in Diffuse, Intrinsic Pontine Glioma (DIPG) [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating Atengenal and Astugenal for diffuse intrinsic pontine glioma has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Intrinsic Pontine Glioma

Drugs mentioned

• Astugenal
• Atengenal

Snippet

Sponsor: Burzynski Research Institute | Conditions: Diffuse, Intrinsic Pontine Glioma | Phase 2 | Status: SUSPENDED